Moderna Inc. (0QF)
XSTU
Real-time Data
06:00 AM
Day's Range
131.5852 wk Range
19.40Overview - 0QF - Moderna Inc.
Key Statistics
Valuation
Enterprise Value
-1.29B
P/E (Trailing)
‪-18.38‬
PEG Ratio
‪2.44‬
Price / Book
‪7.85‬
EV / EBITDA
‪0.50‬
Profitability
Gross Margin
‪34.96%‬
Profit Margin
‪54.83%‬
Operating Margin
‪-143.49%‬
Return on Assets
‪-22.87%‬
Return on Equity
‪-32.62%‬
Ownership
Shares Outstanding
399.00M
Price stats
50-Day Avg
‪84.72‬
200-Day Avg
‪52.59‬
Peers - 0QF - Moderna Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XSTU.
- 0QFXSTUModerna Inc.+83.17%52-week change-18.38P/E (Trailing)‪54.83%‬Profit Margin
- 37TXSTUForte Biosciences, Inc.+86.11%52-week change-13.91P/E (Trailing)—Profit Margin
- 3920XSTUSpyre Therapeutics, Inc.+81.45%52-week change-38.38P/E (Trailing)—Profit Margin
- 0MEXSTUTwist Bioscience Corporation+80.18%52-week change-84.15P/E (Trailing)‪50.72%‬Profit Margin
- 5NRXSTUNanobiotix S.A.+78.42%52-week change—P/E (Trailing)—Profit Margin
- 3O8XSTUOmeros Corp.+77.40%52-week change-323.00P/E (Trailing)—Profit Margin
- 87EXSTUDianthus Therapeutics Inc.+76.34%52-week change-22.14P/E (Trailing)—Profit Margin
Profile Summary - 0QF - Moderna Inc.
About
Moderna Inc. is a biotechnology company focused on developing medicines and vaccines based on messenger RNA (mRNA) technology. Its commercial portfolio includes respiratory and infectious disease vaccines, while its broader pipeline spans oncology, rare diseases, autoimmune conditions, and other therapeutic areas.…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
